Physician
Women's Health Associates of Southern Nevada- Martin, PLLC
Women's Health Associates of Southern Nevada- Martin, PLLC was paid $22.61M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoWOMEN'S HEALTH ASSOCIATES OF SOUTHERN NEVADA- MARTIN, PLLC
LAS VEGAS, NV 89148
LAS VEGAS, NV 89148
33aNPI1598906166assigned 03/11/2009
33bProvider typeObstetrics & Gynecology Physician
28Total paid$22.61M
24GClaims576,114
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Nevada
Rank by total paid#1 of 159
Median peer was paid$15K
This provider vs. median1,462×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,861 | $211K | |
| 2019 | 55,371 | $2.52M | |
| 2020 | 89,359 | $3.25M | |
| 2021 | 96,544 | $3.79M | |
| 2022 | 105,402 | $4.26M | |
| 2023 | 130,237 | $5.10M | |
| 2024incomplete | 94,340 | $3.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 93,007 | 83,289 | $5.60M |
| 76830 | Ultrasound, transvaginal | 13% | 22,352 | 20,320 | $2.92M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 26,113 | 23,126 | $2.22M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.1% | 48,332 | 42,811 | $1.15M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.1% | 48,205 | 42,716 | $1.14M |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 4.1% | 485 | 439 | $926K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4.0% | 7,438 | 6,773 | $909K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.4% | 7,711 | 7,216 | $763K |
| 87660 | 3.2% | 52,645 | 46,197 | $722K | |
| 87510 | 3.2% | 52,675 | 46,197 | $722K | |
| 87480 | 3.2% | 52,666 | 46,180 | $722K | |
| 99219 | 2.4% | 4,986 | 4,158 | $543K |
96 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.2% | 4,312 | $508K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.1% | 3,207 | $479K |
| 76818 | 1.7% | 2,907 | $376K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.5% | 4,176 | $340K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.5% | 3,801 | $337K |
| 59514 | 1.5% | 1,842 | $330K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.3% | 2,792 | $283K |
| 99459 | <1% | 10,182 | $173K | |
| 76813 | <1% | 1,068 | $137K | |
| 59510 | <1% | 80 | $124K | |
| 81025 | <1% | 23,688 | $100K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,552 | $94K |
| 99385 | <1% | 746 | $74K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 481 | $72K |
| 86780 | <1% | 6,677 | $63K | |
| 84702 | <1% | 5,190 | $48K | |
| 86803 | <1% | 4,638 | $48K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,357 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,271 | $41K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,004 | $40K |
| 87340 | <1% | 4,394 | $39K | |
| 59025 | Fetal non-stress test | <1% | 965 | $34K |
| 80050 | General health panel | <1% | 1,283 | $32K |
| 76857 | <1% | 541 | $29K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 559 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,267 | $23K |
| 84146 | <1% | 1,612 | $22K | |
| 86696 | <1% | 1,342 | $19K | |
| 84403 | <1% | 861 | $16K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 176 | $16K |
| 81002 | <1% | 10,080 | $16K | |
| 83001 | <1% | 1,187 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,499 | $15K |
| 84144 | <1% | 1,011 | $15K | |
| 82670 | <1% | 746 | $15K | |
| 80061 | Lipid panel | <1% | 1,480 | $14K |
| 87653 | <1% | 479 | $13K | |
| 83002 | <1% | 896 | $12K | |
| 84270 | <1% | 693 | $11K | |
| 86695 | <1% | 1,001 | $10K | |
| 0503F | <1% | 1,559 | $9K | |
| 82627 | <1% | 557 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 352 | $9K |
| 86762 | <1% | 1,023 | $9K | |
| 87481 | <1% | 387 | $9K | |
| 84439 | <1% | 1,501 | $8K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 65 | $8K |
| 96160 | <1% | 2,081 | $8K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 139 | $7K |
| 80053 | Comprehensive metabolic panel | <1% | 1,016 | $7K |
| 96127 | <1% | 1,687 | $7K | |
| 86850 | <1% | 1,123 | $5K | |
| 84481 | <1% | 446 | $5K | |
| 93975 | <1% | 14 | $5K | |
| 99070 | <1% | 416 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 175 | $4K |
| 82533 | <1% | 320 | $4K | |
| 82950 | <1% | 1,103 | $4K | |
| 99218 | <1% | 63 | $4K | |
| 82728 | <1% | 405 | $4K | |
| 0500F | <1% | 1,701 | $4K | |
| H0049 | Alcohol and/or drug screening | <1% | 655 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 209 | $3K |
| A4550 | Surgical trays | <1% | 195 | $3K |
| 83525 | <1% | 314 | $3K | |
| 87529 | <1% | 108 | $3K | |
| 86900 | <1% | 1,340 | $3K | |
| 86901 | <1% | 1,342 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,280 | $2K |
| 80055 | <1% | 41 | $2K | |
| 76820 | <1% | 31 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 66 | $2K |
| 87210 | <1% | 444 | $1K | |
| 99283 | Emergency room visit (moderate) | <1% | 22 | $1K |
| 57410 | <1% | 16 | $933.15 | |
| 85027 | <1% | 191 | $848.13 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 29 | $838.97 |
| 58300 | <1% | 14 | $700.71 | |
| 82951 | <1% | 59 | $454.27 | |
| 57465 | <1% | 13 | $420.61 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 28 | $394.80 |
| 90658 | <1% | 32 | $209.38 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,014 | $148.22 |
| 87077 | <1% | 19 | $129.06 | |
| 84703 | <1% | 20 | $73.92 | |
| E0445 | Oximeter device for measuring blood oxygen levels non-invasively | <1% | 108 | $50.00 |
| 99000 | <1% | 6,496 | $47.41 | |
| 81001 | <1% | 13 | $39.50 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 46 | $26.27 |
| 3725F | <1% | 233 | $0.05 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 331 | $0.00 |
| 0502F | 0% | 1,070 | $0.00 | |
| 99051 | 0% | 146 | $0.00 | |
| 1031F | 0% | 66 | $0.00 | |
| 1036F | 0% | 292 | $0.00 | |
| 99024 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNESBITT, CHARMAINE (CONTRACTING)